Table V.

Serum adipokines in 116 survivors of acute lymphoblastic leukemia by gender, by overweight and obese (BMI^* ≥ 25 kg/m²) versus not (BMI < 25 kg/m²), and by insulin resistant (HOMA-IR ≥ 2.86)^** versus not (HOMA-IR < 2.86).

	Females		p	Males		p	BMI < 25 kg/m2		p	BMI ≥ 25 kg/m2		p
	HOMA-IR			HOMA-IR			HOMA-IR			HOMA-IR
	< 2.86	≥ 2.86		< 2.86	≥ 2.86		< 2.86	≥ 2.86		< 2.86	≥ 2.86
	N=23	N=41		N=23	N=41		N=22	N=18		N=20	N=54
	Mean (SD)	Mean (SD)		Mean (SD)	Mean (SD)		Mean (SD)	Mean (SD)		Mean (SD)	Mean (SD)
Leptin per kg fat (ng/mL/kg)	0.7 (0.3)	0.8 (0.3)	0.1	0.3 (0.2)	0.4 (0.2)	0.01	0.5 (0.3)	0.5 (0.3)	0.9	0.5 (0.3)	0.7 (0.4)	0.03
Adiponectin per kg fat (μg/mL/kg)	0.6 (0.5)	0.5 (0.4)	<0.01	1.1 (0.8)	0.5 (0.5)	<0.01	1.3 (0.6)	1.0 (0.5)	0.2	0.6 (0.2)	0.3 (0.2)	<0.01
Leptin to adiponectin ratio	1.0 (0.7)	2.8 (2.1)	<0.01	0.4 (0.4)	1.7 (2.3)	<0.01	0.5 (0.6)	0.6 (0.4)	0.4	1.0 (0.7)	2.9 (2.4)	<0.01

^*BMI: body mass index;

^**Homeostasis model of insulin resistance (HOMA-IR) ≥ 2.86 indicates above the 75^th percentile for HOMA-IR derived from the Third National Health and Nutrition Examination Survey.(15)